Envy Medical is one of the most technologically innovative dermatology and medical aesthetics companies. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with Advanced Dermalinfusion® Technology for deeper tissue delivery of active ingredients and better patient outcomes (silkpeel.com). Envy is also the developer of the patent pending ClarityMD™ Acne Solution brand of acne treatment products (claritymdacne.com) and is the exclusive worldwide licensor of skin brightening peptides, including the Lumixyl® peptide, developed at Stanford University (lumixyl.com).
THE GORGEOUS GIVEAWAY
In celebration of our 7th year anniversary, we
Photo Credit: Envy Medical
Got spots, zits, pimples? What you really want is fast, powerful relief —but without the irritation, redness and flaking of some prescription drugs.
The ClarityMD Acne Solution System from Envy Medical is a simple 2-step system that consists of the gentle, yet effective Deep Pore Cleanser and the amazing Clarifying Gel. In fact, a recent study showed volunteers achieved a 59% clearance of acne in just 7 days, and over 90% in 14 days.
The patent-pending formula contains PCX Technology, a revolutionary multifunctional formulation that addresses all of the primary causes of acne. ClarityMD is the first and only acne treatment to feature fully solubilized bakuchiol (a strong antimicrob
In honor of Acne Awareness Month, which ends on June 30, we have news of a new approach to clearing up blemishes, the ClarityMD™ Acne Solution. Previewed at the AAD conference in Miami last March by Envy Medical Inc., the creators of the Lumixyl® skin brightening system, ClarityMD™ is clinically proven to significantly clear both inflammatory and non-inflammatory acne within days, plus it works three times faster than comparable topical prescription and over the counter acne treatments.
“Even the best acne products can take up to six weeks to work, however, unpleasant side effects from these regimens, including dryness and irritation often cause patients to stop using the produc